Margreet Wagenmakers

8PUBLICATIONS
16CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Clinical pharmacology and therapeuticsEnvironmental epidemiologyEpidemiological modellingMedical biochemistry - lipids
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 28, 2026
Unfavorable cardiovascular risk profile without increased event prevalence in late-onset Pompe disease: an individually matched cohort study.

|Dec 03, 2024
Mapping challenges in the accessibility of treatment products for urea cycle disorders: A survey of European healthcare professionals.

Nina N Stolwijk, Johannes Häberle, Hidde H Huidekoper

|Dec 29, 2022
Erythropoietic protoporphyria in the Netherlands: Clinical features, psychosocial impact and the effect of afamelanotide.

Debby Wensink, Margreet A E M Wagenmakers, J H Paul Wilson

|Dec 23, 2022
Mortality in Pedigrees with Acute Intermittent Porphyria.

Rochus Neeleman, Kyra Musters, Margreet Wagenmakers

|Nov 07, 2022
Orofacial abnormalities in mucopolysaccharidosis and mucolipidosis type II and III: A systematic review.

Chiel J de Bode, Emma J Dogterom, Antoinette V J Rozeboom

|Jan 28, 2021
Afamelanotide for prevention of phototoxicity in erythropoietic protoporphyria.

Debby Wensink, Margreet A E M Wagenmakers, Janneke G Langendonk

Pageof 2

Frequent Collaborators

4 joint publications

Janneke Langendonk

2 joint publications

Debby Wensink

1 joint publications

Michiel Bongaerts

1 joint publications

Robert M W Hofstra